Research and Markets: Analyzing the Global Pharmaceutical Industry 2013

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/r72qwf/analyzing_the) has announced the addition of the "Analyzing the Global Pharmaceutical Industry" report to their offering.

The birth origins of the Pharmaceutical Industry can be traced back to more humble antecedents than just chemistry labs. The earliest incidents of recognition of the antiseptic properties of the dyestuffs is around the late 19th century. The invention of penicillin can yet be recognized as a major milestone for the emergent industry which firmly consolidated its R&D efforts in the 1950's. Further in the 1960's the patent regulation support gave a further impetus to the industry in new discoveries and relaxed controls on clinical development with the booming spend on healthcare as economies boomed globally.

The global presence of the pharmaceutical industry is evident with the roll out of continent specific R&D programs and drugs which help companies maximize penetration of markets and garner increased revenues with inter continental treatment demand of patients being serviced from often one or two mega research centers in the continent.

By contribution of size, the pharmaceutical industry is majorly dominant at the US, Europe and Japan. Led by these markets, the total world consumption in sales of pharmaceutical products has displayed strong growth and is expected to grow further with expanding populations in emerging markets.

The marketing aggressiveness of US-based companies has placed them at the top of the pile, being followed closely by the European sector. Countries like the UK, France and Denmark each have at least two pharmaceutical companies in their respective ten largest corporate enterprises.

Key Topics Covered:

A. Executive Summary

Section 1: Analyzing the Global Pharmaceutical Industry

B. Historical Perspective of the Global Pharmaceutical Industry

C. Introduction to the Global Pharmaceutical Industry

D. Introduction to the Global OTC Pharmaceutical Industry

E. Introduction to the Global Generics Industry

F. Understanding the Industry Structure

G. Analyzing the Industry

H. Understanding the Drug Development Process

I. Analyzing Pricing & Investment Scenarios Globally

J. The TRIPS Agreement & the Global Pharmaceutical Market

K. Challenges in Corporate Social Responsibility for Developing Countries

L. Other Corporate Social Responsibility Challenges

M. Intellectual Asset Protection in the Global Pharmaceutical Industry

N. Offshoring in the Pharmaceutical Sector

Section 2: Analyzing the Global Pharmaceutical Markets Under Following Criteria

• 1 Industry Overview & Statistics
• 2 Market Segments & Market Share
• 3 Competition in the Industry
• 4 Future Outlook

Section 3: Analyzing the Major Market Players

Section 4: Conclusion

A. Appendix

B. Glossary of Terms

Companies Mentioned

- Abbott Laboratories

- Altana AG

- Amgen

- AstraZeneca

- Baxter International

- Bayer AG

- Boehringer Ingelheim Germany

- Bristol-Myers Squibb

- Daewoong Pharmaceutical Co Ltd.

- Daiichi Pharmaceutical Co., Ltd.

- Dong-A Pharmaceutical Co. Ltd

- Dr. Reddy's Laboratories Limited

- Eli Lilly and Company

- Fresenius AG

- Gedeon Richter Ltd

- GlaxoSmithKline

- Hoffmann-La Roche

- IVAX Corporation

- Johnson & Johnson

- Merck & Co.

- Piramal Healthcare

- Novartis

- Pfizer

- Sanofi SA

- Schering-Ploug

- Takeda Pharmaceutical Company Limited

- Teva Pharmaceutical Industries

- Wyeth

- Zentiva, A.S.

For more information visit http://www.researchandmarkets.com/research/r72qwf/analyzing_the